The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors-Reference-Cited by-同舟云学术

The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors

Published:2016-10-27 Issue:4 Volume:2 Page:449-463
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Hoffmann Michèle J.¹,Koutsogiannouli Evangelia¹,Skowron Margaretha A.¹,Pinkerneil Maria¹,Niegisch Günter¹,Brandt Artur²,Stepanow Stefanie³,Rieder Harald²,Schulz Wolfgang A.¹

Affiliation:

1. Department of Urology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

2. Institute for Human Genetics, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

3. Biological and Medical Research Center (BMFZ), Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Publisher

IOS Press

Subject

Urology,Oncology

Reference51 articles.

1. Normal human urothelial cells in vitro: Proliferation and induction of stratification;Southgate;Lab Invest,1994

2. A biomimetic tissue from cultured normal human urothelial cells: Analysis of physiological function;Cross;Am J Physiol Renal Physiol,2005

3. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme;Varley;J Cell Sci,2004

4. Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells;Kao;Carcinogenesis,1993

5. The immortalized UROtsa cell line as a potential cell culture model of human urothelium;Rossi;Environ Health Perspect,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma;Journal of Cellular and Molecular Medicine;2024-05

2. Insulin receptor signaling engages bladder urothelial defenses that limit urinary tract infection;Cell Reports;2024-04

3. Repurposing HDAC inhibitors to enhance ribonuclease 4 and 7 expression and reduce urinary tract infection;Proceedings of the National Academy of Sciences;2023-01-18

4. Epigenetic Priming and Development of New Combination Therapy Approaches;Urothelial Carcinoma;2023

5. Differential DNA Methylation of THOR and hTAPAS in the Regulation of hTERT and the Diagnosis of Cancer;Cancers;2022-09-08